Prokaryotically and eukaryotically expressed interleukin-24 induces breast cancer growth suppression via activation of apoptosis and inhibition of tumor angiogenesis. [electronic resource]
- Molecular medicine reports May 2015
- 3673-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-3004
10.3892/mmr.2014.3136 doi
Angiogenesis Inhibitors--pharmacology Animals Apoptosis--drug effects Breast Neoplasms--drug therapy Caspase 3--metabolism Cell Line, Tumor Cell Proliferation--drug effects Disease Models, Animal Female Humans Interleukins--pharmacology Male Mice Neovascularization, Pathologic--drug therapy Proto-Oncogene Proteins c-bcl-2--metabolism Recombinant Proteins--pharmacology Xenograft Model Antitumor Assays bcl-2-Associated X Protein--metabolism